Adviser

Lucid Capital Markets, LLC.

Fairness opinion, Financial adviser on 3 live deals, from 20 Aug 2025 to 3 Dec 2025. Also written as Lucid Capital Markets.

03Live deals
05Other advisers
01

Deals

DateDealStageRoleSector
3 Dec 2025Hyperliquid Strategies Inc / Sonnet BioTherapeutics Holdings, Inc.Closed
  • Fairness opinion to the targetSource-verified
Not stated
10 Nov 2025Galecto, Inc. / Damora Therapeutics, Inc.Closed
  • Financial adviser to the targetSource-verified
Healthcare
20 Aug 2025XOMA Royalty Corporation / Mural Oncology plcAgreement signed
  • Fairness opinion to the targetSource-verified
  • Financial adviser to the targetSource-verified
Healthcare
02

By year, sector and stage

20253
Healthcare2
Not stated1
Closed2
Agreement signed1
03

Other advisers on the same deals

AdviserShared dealsAcross the tableAlongside
Lucid202
Gibson, Dunn & Crutcher LLP101
Lowenstein Sandler LLP101
Scheme Shareholders101
Wedbush PacGrow101